Your browser doesn't support javascript.
loading
Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaques.
Klasse, P J; Ketas, Thomas J; Cottrell, Christopher A; Ozorowski, Gabriel; Debnath, Gargi; Camara, Diawoye; Francomano, Erik; Pugach, Pavel; Ringe, Rajesh P; LaBranche, Celia C; van Gils, Marit J; Bricault, Christine A; Barouch, Dan H; Crotty, Shane; Silvestri, Guido; Kasturi, Sudhir; Pulendran, Bali; Wilson, Ian A; Montefiori, David C; Sanders, Rogier W; Ward, Andrew B; Moore, John P.
Afiliação
  • Klasse PJ; Department of Microbiology and Immunology, Weill Cornell Medical College, New York, New York, United States of America.
  • Ketas TJ; Department of Microbiology and Immunology, Weill Cornell Medical College, New York, New York, United States of America.
  • Cottrell CA; Department of Integrative Structural and Computational Biology, IAVI Neutralizing Antibody Center and Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, La Jolla, California, United States of America.
  • Ozorowski G; Department of Integrative Structural and Computational Biology, IAVI Neutralizing Antibody Center and Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, La Jolla, California, United States of America.
  • Debnath G; Department of Microbiology and Immunology, Weill Cornell Medical College, New York, New York, United States of America.
  • Camara D; Department of Microbiology and Immunology, Weill Cornell Medical College, New York, New York, United States of America.
  • Francomano E; Department of Microbiology and Immunology, Weill Cornell Medical College, New York, New York, United States of America.
  • Pugach P; Department of Microbiology and Immunology, Weill Cornell Medical College, New York, New York, United States of America.
  • Ringe RP; Department of Microbiology and Immunology, Weill Cornell Medical College, New York, New York, United States of America.
  • LaBranche CC; Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.
  • van Gils MJ; Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Bricault CA; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
  • Barouch DH; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
  • Crotty S; Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America.
  • Silvestri G; Scripps Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, La Jolla, California, United States of America.
  • Kasturi S; School of Medicine, Division of Infectious Diseases, University of California, San Diego, La Jolla, California, United States of America.
  • Pulendran B; Scripps Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, La Jolla, California, United States of America.
  • Wilson IA; Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.
  • Montefiori DC; Emory Vaccine Center/Yerkes National Primate Research Center at Emory University, Atlanta, Georgia, United States of America.
  • Sanders RW; Emory Vaccine Center/Yerkes National Primate Research Center at Emory University, Atlanta, Georgia, United States of America.
  • Ward AB; Emory Vaccine Center/Yerkes National Primate Research Center at Emory University, Atlanta, Georgia, United States of America.
  • Moore JP; Department of Integrative Structural and Computational Biology, IAVI Neutralizing Antibody Center and Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, La Jolla, California, United States of America.
PLoS Pathog ; 14(2): e1006913, 2018 02.
Article em En | MEDLINE | ID: mdl-29474444

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Anti-HIV / HIV-1 / Produtos do Gene env do Vírus da Imunodeficiência Humana / Anticorpos Neutralizantes / Epitopos Limite: Animals Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Anti-HIV / HIV-1 / Produtos do Gene env do Vírus da Imunodeficiência Humana / Anticorpos Neutralizantes / Epitopos Limite: Animals Idioma: En Ano de publicação: 2018 Tipo de documento: Article